Please assess the completion status of the following clinical trial:

Trial Title: A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adults with histologically or cytologically confirmed breast adenocarcinoma~* radiographic evidence of at least one bone mets~* Easter Cooperative Oncology Group status of 0, 1 or 2;~* adequate organ function~Exclusion Criteria:~* Current or prior IV bisphosphonate administration~* current or prior oral bisphosphonates for bone mets~* life expectancy of less than 6 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- zoledronic acid (Type: ACTIVE_COMPARATOR): None
- denosumab (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).